Efficacy and Safety of JT001 (VV116) Compared With Favipiravir
Status:
Not yet recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of JT001 (VV116) for the
Treatment of Coronavirus Disease 2019 (COVID-19) in participants with moderate to severe
COVID-19.